Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure
By E. Perin, H. F. Dohmann, R. Borojevic, S. Silva, A. Sousa, C. Mesquita, M. D. Rossi, A. C. Carvalho, H. Dutra, G. Silva and 9 more. Circulation, 2003
1,373 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/056b6331fbf1f65cab77c2b49185bbae56923a67
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- M. Schneider
- K. Urbanek
- A. Beltrami
- D. Torella
- Laura Barlucchi
- U. Galderisi
- S. Chimenti
- J. Kajstura
Citations in the corpus
- Mesenchymal stem cells and their potential as cardiac therapeutics. (2004, background): “The hMSCs, with their attributes of (1) ease of isolation, (2) high expansion potential, (3) genetic stability, (4) reproducible attributes from isolate to isolate, (5) reproducible characteristics in widely dispersed laboratories, (6) compatibility with tissue engineering principles, and (7) potent”
- From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells (2007, background): “The 4-month follow-up revealed an improvement in ejection fraction and a reduction in end-systolic volume in the treated patients (Perin et al., 2003).”
- Unchain my heart: the scientific foundations of cardiac repair. (2005, methodology): “14 Endocardial injection, guided BMCs 50 ml/Ficoll/none 30 + Global contractility ↓; (14, 18) by electromechanical mapping endsystolic volumes ↓; reversible perfusion defects ↓; exercise capacity ↑”
- Adult cardiac stem cells are multipotent and support myocardial regeneration. (2003, positive): “Recently, there tracked, the different outcomes might represent another has been a flurry of reports of human myocardial therapy example of the differences between normal developusing bone marrow cells (Strauer et al., 2002; Assmus mental fate and developmental potential. Alternatively, it et al., 2”